Skip to main content
. 2017 Jan;9(1):123–128. doi: 10.21037/jtd.2017.01.25

Figure 1.

Figure 1

Waterfall plots for change in tumor burden are shown for patients who had received palliative chemotherapy with cisplatin and docetaxel. The response rate was 83.3% (10 of 12 patients). (The dashed line at 20% represents the boundary for determination of progressive disease, and the dashed line at −30% represents the boundary for determination of partial response.)